Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
John Hancock Preferred Income Fund III	HPS	29. nov 2024	15.76	+1.03
John Hancock Premium Dividend Fund	PDT	29. nov 2024	13.23	+1.22
John Hancock Tax Advantaged Dividend Fund	HTD	29. nov 2024	23.64	+0.38
John Marshall Bancorp	JMSB	29. nov 2024	22.65	-1.91
John Wiley & Sons A	WLY	29. nov 2024	52.18	-0.46
John Wiley & Sons B	WLYB	29. nov 2024	52.90	0.00
Johnson & Johnson	JNJ	29. nov 2024	155.01	-0.25
Johnson Controls International	JCI	29. nov 2024	83.86	+0.18
Johnson Outdoors A	JOUT	29. nov 2024	33.66	+1.11
Joint Stock Company Kaspi.kz	KSPI	29. nov 2024	106.40	-2.15
Jones Lang LaSalle	JLL	29. nov 2024	280.60	-0.57
Journey Medical	DERM	29. nov 2024	5.78	+4.14
Jowell Global	JWEL	29. nov 2024	3.13	-7.94
JOYY ADR	YY	29. nov 2024	38.85	+0.39
JP Morgan Chase	JPM	29. nov 2024	249.72	-0.03
JP Morgan Chase & Co EE Pref	JPM-C	29. nov 2024	25.26	-0.55
JP Morgan Chase & Co GG Pref	JPM-J	29. nov 2024	22.08	-0.14
JP Morgan Chase & Co Ser DD Pref	JPM-D	29. nov 2024	25.06	-0.12
JPMorgan Nasdaq Equity Premium Income ETF	JEPQ	29. nov 2024	57.09	+0.72
Jumia Technologies ADR	JMIA	29. nov 2024	3.90	-2.01
Junee Limited - Ordinary Shares	JUNE	29. nov 2024	4.50	-4.66
Junior Gold Miners ETF Market Vectors	GDXJ	29. nov 2024	47.68	+1.08
Juniper Networks	JNPR	29. nov 2024	35.92	-0.42
JVSPAC Acquisition	JVSA	29. nov 2024	10.40	+0.10
JVSPAC Acquisition	JVSAU	29. nov 2024	10.90	0.00
JX Luxventure	JXJT	29. nov 2024	1.21	-3.20
Kadant	KAI	29. nov 2024	412.79	+2.31
Kairos Pharma	KAPA	29. nov 2024	1.54	0.00
Kairous Acquisition	KACL	29. nov 2024	12.46	0.00
Kaiser Aluminium	KALU	29. nov 2024	81.28	-0.47

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.